|
|
|
0 members (),
3,202
guests, and
26
robots. |
|
Key:
Admin,
Global Mod,
Mod
|
|
S |
M |
T |
W |
T |
F |
S |
|
|
|
|
|
1
|
2
|
3
|
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
|
11
|
12
|
13
|
14
|
15
|
16
|
17
|
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
|
25
|
26
|
27
|
28
|
29
|
30
|
31
|
|
There are no members with birthdays on this day. |
World Earthquake Report for Friday, 2 October 2026
• M 5.0 - 6 km E of Inglewood, New Zealand
• M 1.2 - 7 km N of Beaumont, CA
• M 1.2 - 12 km WNW of Calipatria, CA
• M 5.0 - 6 km E of Inglewood, New Zealand
• M 5.0 - 6 km E of Inglewood, New Zealand
|
#314338
Mon 29 Jun 2015 04:45:PM
|
Joined: Feb 2001
Posts: 678,977
Launch Director
|
|
Launch Director
Joined: Feb 2001
Posts: 678,977 |
Clinicians testing the drug dasatinib, approved for several blood cancers, had hoped it would slow the aggressive growth of the deadly brain cancer glioblastoma; however, clinical trials to date have not found any benefit. Researchers who conducted one of those clinical trials, believe they know why dasatinib failed — and what to do about it.  Source: Predicting which glioblastoma patients may benefit from drug treatment
David Cottle
UBB Owner & Administrator
|
|
CMS The Best Conveyancing solicitors conveyancing quotes throughout the UK
For any webhosting enquiries please email webmaster@aus-city.com
|
|
Entire Thread
|
Predicting which glioblastoma patients may benefit from drug treatment
|
Webmaster
|
Mon 29 Jun 2015 04:45:PM
|
|
Forums60
Topics853,347
Posts888,142
Members2,960
| |
Most Online102,106
Jul 10th, 2026
|
|
|
|
|
|
